论文部分内容阅读
Theratechnologies公司多年来致力于细胞治疗领域,尤以干细胞技术而闻名。为加强转化其体外光动力细胞治疗技术(Theralux) ,Theratechnologies公司于2 0 0 1年6月创立了CelmedBioSciences公司。2 0 0 3年4月2 8日Celmed公司宣布,美国FDA对该公司Theralux授予了罕见病用药的称号
Theratechnologies company for many years committed to the field of cell therapy, especially in stem cell technology is known. Theratechnologies founded CelmedBioSciences in June 2001 in an effort to transform its in vitro photodynamic cell therapy (Theralux) technology. April 28, 2003 Celmed Corporation announces that the U.S. FDA awarded the company Theralux the title of a rare disease drug